Healthcare provider profile · identity verified

Robin Mckelvey, MD

Internal Medicine · CORVALLIS, OR · NPI 1730228727

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	415	126
Atorvastatin Calcium	Atorvastatin Calcium	387	130
Lisinopril	Lisinopril	333	105
Rosuvastatin Calcium	Rosuvastatin Calcium	312	101
Metoprolol Succinate	Metoprolol Succinate	285	95
Amlodipine Besylate	Amlodipine Besylate	260	91
Omeprazole	Omeprazole	251	78
Losartan Potassium	Losartan Potassium	227	85
Gabapentin	Gabapentin	213	59
Hydrochlorothiazide	Hydrochlorothiazide	180	57
Citalopram Hbr	Citalopram Hydrobromide	143	42
Oxycodone Hcl	Oxycodone Hcl	128	33
Metformin Hcl	Metformin Hcl	125	39
Simvastatin	Simvastatin	114	37
Pantoprazole Sodium	Pantoprazole Sodium	110	39
Eliquis	Apixaban	109	33
Alendronate Sodium	Alendronate Sodium	103	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	32
Tramadol Hcl	Tramadol Hcl	95	31
Ozempic	Semaglutide	93	18
Albuterol Sulfate Hfa	Albuterol Sulfate	92	39
Furosemide	Furosemide	91	29
Trazodone Hcl	Trazodone Hcl	90	33
Sertraline Hcl	Sertraline Hcl	89	29
Bupropion Xl	Bupropion Hcl	86	26
Clonazepam	Clonazepam	86	15
Mirtazapine	Mirtazapine	80	17
Potassium Chloride	Potassium Chloride	79	31
Chlorthalidone	Chlorthalidone	77	26
Fluoxetine Hcl	Fluoxetine Hcl	68	16
Atenolol	Atenolol	67	18
Clopidogrel	Clopidogrel Bisulfate	67	24
Metformin Hcl Er	Metformin Hcl	66	27
Carvedilol	Carvedilol	62	20
Spironolactone	Spironolactone	61	20
Pravastatin Sodium	Pravastatin Sodium	60	20
Estradiol	Estradiol	57	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	14
Metoprolol Tartrate	Metoprolol Tartrate	53	21
Tamsulosin Hcl	Tamsulosin Hcl	53	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	21
Tizanidine Hcl	Tizanidine Hcl	52	15
Duloxetine Hcl	Duloxetine Hcl	50	17
Lorazepam	Lorazepam	50	21
Venlafaxine Hcl Er	Venlafaxine Hcl	50	13
Jardiance	Empagliflozin	49	13
Amitriptyline Hcl	Amitriptyline Hcl	47	12
Donepezil Hcl	Donepezil Hcl	46	14
Zolpidem Tartrate	Zolpidem Tartrate	46	22
Hydroxyzine Hcl	Hydroxyzine Hcl	43	19
Escitalopram Oxalate	Escitalopram Oxalate	42	17
Fluticasone Propionate	Fluticasone Propionate	39	13
Meloxicam	Meloxicam	38	14
Montelukast Sodium	Montelukast Sodium	37	12
Ezetimibe	Ezetimibe	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	12
Pregabalin	Pregabalin	36	16
Warfarin Sodium	Warfarin Sodium	36	suppressed
Famotidine	Famotidine	35	13
Lovastatin	Lovastatin	34	11
Topiramate	Topiramate	33	suppressed
Acyclovir	Acyclovir	32	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Alprazolam	Alprazolam	31	16
Prednisone	Prednisone	31	16
Allopurinol	Allopurinol	30	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Baclofen	Baclofen	28	14
Levetiracetam	Levetiracetam	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Cephalexin	Cephalexin	26	18
Mounjaro	Tirzepatide	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Finasteride	Finasteride	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	14
Trulicity	Dulaglutide	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Fluconazole	Fluconazole	18	12
Gemfibrozil	Gemfibrozil	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Testosterone	Testosterone	17	suppressed
Torsemide	Torsemide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Lactulose	Lactulose	16	suppressed
Linzess	Linaclotide	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Clonidine	Clonidine	15	suppressed
Temazepam	Temazepam	15	suppressed
Constulose	Lactulose	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nystatin	Nystatin	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Travoprost	Travoprost	13	suppressed
Valsartan	Valsartan	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Alphagan P	Brimonidine Tartrate	12	suppressed
Azithromycin	Azithromycin	12	11
Ciclopirox	Ciclopirox	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Isentress	Raltegravir Potassium	12	suppressed
Mesalamine	Mesalamine	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Imiquimod	Imiquimod	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error